MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2025 International Congress

    Temporal Trends in Parkinson’s Disease Related Mortality from 1999-2023: A National Analysis pre and post COVID

    N. Bujala, R. Shi, J. Javeid, Z. Xu, F. Yu (New York, USA)

    Objective: To examine the trends and impact of COVID-19 on Parkinson’s disease (PD) mortality stratified by gender, race and region among older adults in the…
  • 2025 International Congress

    Morbidity and Mortality Associated with Aspiration Pneumonia: Nationwide Trends in Inpatient Therapy Utilization in Parkinson’s Disease Hospitalization

    T. Mehta, H. Kamo, R. Burke, M. Rem, M. Okun, C. Hess (Gainesville, USA)

    Objective: To characterize inpatient therapy utilization and the impact of aspiration pneumonia (AP) on morbidity, mortality, and outcomes in hospitalized Parkinson’s disease (PD) patients. Background:…
  • 2025 International Congress

    Parkinson’s disease GWAS-linked SNCA carriers show slower non-motor and cognitive progression

    DX. Deng, LT. Tan, TEK. Tan (singapore, Singapore)

    Objective: To investigate the disease progression between SNCA rs6826785 C allele carriers and noncarriers over 5 years. Background: A genome-wide association study-linked variant (SNCA rs6826785) was shown to have…
  • 2025 International Congress

    Parkinson’s Disease Epidemiology and Treatment Characteristics in Australia

    M. Lubomski, A. Evans, R. Mackinnon, R. Rossiter, M. Falster, M. Kouhkamari, T. Suresh, A. Mikolaizak, J. Waern (St Leonards, Australia)

    Objective: This project aims to identify epidemiological characteristics specific to people diagnosed with Parkinson’s disease (PD) treated with PD medications or device-aided therapies in New…
  • 2025 International Congress

    Bias in Pharmacoepidemiological Studies of Parkinson’s Disease Prescribing Patterns: A Systematic Review

    K. Orayj (Abha, Saudi Arabia)

    Objective: This systematic review aims to identify and evaluate reported biases in pharmacoepidemiological studies on nonrandomized prescribing patterns, drug utilization, or treatment trends in PD.…
  • 2025 International Congress

    A Study Of Axial Postural Abnormality In Parkinson`s

    V. Rama Raju (Hyderabad, India)

    Objective: APA involves distinct modes plus sequence patterns and proven predictors for every APA remains mystery. The goal is to probe the progress of APA…
  • 2025 International Congress

    Predicting the Cognitive-Psychiatric Phenotype of Parkinson’s Disease

    H. Dhanis, J. Potheegadoo, S. Stampacchia, F. Bernasconi, C. Stucker, M. Maradan, L. Thanh, L. Jenni, J-A. Ghika, P. Burkhard, B. Vicki, D. Benninger, J. Horvath, P. Krack, D. de Ville, O. Blanke (Bern, Switzerland)

    Objective: Predict PD patient’s clinical scores from brain activity. Inform on which assessments capture true changes in cortical dynamics caused by PD and explain those…
  • 2025 International Congress

    Influence of Gut Microbiota-Derived TMAO on Disease Severity in Parkinson’s Disease

    S. Virameteekul (Bangkok, Thailand)

    Objective: This study aims to investigate how gut microbiota composition influences trimethylamine N-oxide (TMAO) levels in PD patients and whether TMAO and gut microbiota composition…
  • 2025 International Congress

    Detection and classification of Parkinson’s disease from neuroimaging modalities using machine learning and artificial intelligence: a systematic review

    F. Ebrahimian Sadabad, P. Honhar, S. Houshi, F. Nejati, S. Bagherieh, A. Brackett, F. Yazdanpanah, S. Cayir, M. Hosseini, H. Tagare, D. Matuskey (New Haven, USA)

    Objective: This systematic review evaluates performance of machine learning (ML) and artificial intelligence (AI) techniques applied to neuroimaging modalities in differentiating Parkinson’s disease (PD) patients…
  • 2025 International Congress

    Functional Segregation in Parkinson’s Disease

    DN. Su, J. Hanania, A. Pavel, M. Matarazzo, J. Mckenzie, J. Cheng, N. Vafai, S. Dhaliwal, V. Sossi, A. Stoessl (Beijing, China)

    Objective: We assessed patterns of dopamine (DA) release and striatal activation induced by behavioural tasks involving corticostriatal loops in Parkinson’s disease (PD) and healthy control…
  • « Previous Page
  • 1
  • …
  • 64
  • 65
  • 66
  • 67
  • 68
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley